PMC President: Investments in Biomedical Research Underlie Personalized Medicine Discoveries That ‘Help Americans Live Healthier Lives’
WASHINGTON (February 14, 2018)
The Personalized Medicine Coalition (PMC) today calls on Congress to provide more funding for the National Institutes of Health (NIH) than is outlined in President Donald Trump’s recently released FY 2019 budget proposal and applauds the President for proposing a significant increase to the budget for the U.S. Food and Drug Administration (FDA).
Although Congress recently voted to approve an increase of about $2 billion to NIH’s budget, the President’s proposal allocates an amount to NIH that is roughly equivalent to FY 2017 levels, while increasing the budget for FDA by $473 million. Advancement in personalized medicine, PMC President Edward Abrahams, Ph.D., notes, depends on the strength of both agencies.
PMC demonstrates in its recently released Personalized Medicine at FDA: 2017 Progress Report that personalized medicines account for one of every four new drugs approved in the last four years. Publically funded biomedical research will help pave the way for continued progress.
“PMC encourages Congress to increase NIH’s budget by at least $2 billion in FY 2019 to provide a foundation for discoveries in personalized medicine,” Abrahams said. “As evidenced by [PMC’s report], these discoveries can help Americans live healthier lives.”
Cynthia A. Bens, Senior Vice President, Public Policy, PMC, who is also a board member for the multi-stakeholder Alliance for a Stronger FDA, said the proposed investments in FDA’s staffing needs come at a critical time for personalized medicine.
“Unlike most federal agencies, more than 80 percent of FDA’s budget is dedicated to its personnel needs,” said Bens. “The President’s budget request will help ensure that the agency can secure and retain the highly trained workforce required to carry out its mandate.”
Christopher J. Wells
About the Personalized Medicine Coalition:
The Personalized Medicine Coalition, representing innovators, scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system. For more information about PMC, please visit www.personalizedmedicinecoalition.org.